A novel approach to brain tumor detection using K-Means++, SGLDM, ResNet50, and synthetic data augmentation

一种利用K-Means++、SGLDM、ResNet50和合成数据增强进行脑肿瘤检测的新方法

阅读:1

Abstract

Introduction: Brain tumors are abnormal cell growths in the brain, posing significant treatment challenges. Accurate early detection using non-invasive methods is crucial for effective treatment. This research focuses on improving the early detection of brain tumors in MRI images through advanced deep-learning techniques. The primary goal is to identify the most effective deep-learning model for classifying brain tumors from MRI data, enhancing diagnostic accuracy and reliability. Methods: The proposed method for brain tumor classification integrates segmentation using K-means++, feature extraction from the Spatial Gray Level Dependence Matrix (SGLDM), and classification with ResNet50, along with synthetic data augmentation to enhance model robustness. Segmentation isolates tumor regions, while SGLDM captures critical texture information. The ResNet50 model then classifies the tumors accurately. To further improve the interpretability of the classification results, Grad-CAM is employed, providing visual explanations by highlighting influential regions in the MRI images. Result: In terms of accuracy, sensitivity, and specificity, the evaluation on the Br35H::BrainTumorDetection2020 dataset showed superior performance of the suggested method compared to existing state-of-the-art approaches. This indicates its effectiveness in achieving higher precision in identifying and classifying brain tumors from MRI data, showcasing advancements in diagnostic reliability and efficacy. Discussion: The superior performance of the suggested method indicates its robustness in accurately classifying brain tumors from MRI images, achieving higher accuracy, sensitivity, and specificity compared to existing methods. The method's enhanced sensitivity ensures a greater detection rate of true positive cases, while its improved specificity reduces false positives, thereby optimizing clinical decision-making and patient care in neuro-oncology.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。